These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1175893)

  • 1. Effects of clofibrate in primary biliary cirrhosis hypercholesterolemia and gallstones.
    Summerfield JA; Elias E; Sherlock S
    Gastroenterology; 1975 Oct; 69(4):998-1000. PubMed ID: 1175893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: chenodeoxycholic acid therapy of intrahepatic radiolucent gallstones in a patient with Caroli's syndrome.
    Kutz K; Miederer SE; Paumgartner G
    Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):398-401. PubMed ID: 726807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of gallstones in hyperlipidemia and incidence during treatment with clofibrate and/or cholestyramine.
    Palmer RH
    Trans Assoc Am Physicians; 1978; 91():424-32. PubMed ID: 754401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of intrahepatic cholesterol stones by chenodeoxycholic acid (author's transl)].
    Czygan P; Stiehl A; Fröhling W; Kommerell B; Encke A
    Dtsch Med Wochenschr; 1977 Apr; 102(14):518-20. PubMed ID: 856567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Is intermittent chenodeoxycholic acid therapy feasible for dissolving gallstones? The speed of change in biliary lipids and bile acids after starting and stopping treatment.
    Iser JH; Murphy GM; Dowling RH
    Gut; 1975 Oct; 16(10):840. PubMed ID: 1205324
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholesterolic gallstones. Pathophysiology and treatment (author's transl)].
    Heller F; Harvengt C
    Acta Gastroenterol Belg; 1977; 40(11-12):392-405. PubMed ID: 347866
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology, physiopathology and therapy of drug-induced gallbladder lesions].
    Kajiyama G
    Nihon Naika Gakkai Zasshi; 1995 Feb; 84(2):216-20. PubMed ID: 7722385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chenodeoxycholic acid. Indications in biliary pathology and hyperlipoproteinemias].
    Chevrel B
    Med Chir Dig; 1980; 9(1):31-4. PubMed ID: 7392696
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dissolution of gallstones with and without chenodeoxycholic acid therapy].
    Möckel G
    Verh Dtsch Ges Inn Med; 1974; 80():451-6. PubMed ID: 4454584
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of the treatment with biliary dissolvents].
    Dhumeaux D
    Rev Prat; 1992 Jun; 42(12):1478-81. PubMed ID: 1411169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Internist therapy of cholelithiasis].
    Riemann JF
    Fortschr Med; 1981 May; 99(20):755-60. PubMed ID: 7262755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of liver function and structure in patients with gallstones before and during treatment with chenodeoxycholic acid.
    Fromm H; Holz-Slomczyk M; Zobl H; Schmidt E; Schmidt FW
    Acta Hepatogastroenterol (Stuttg); 1975 Dec; 22(6):359-69. PubMed ID: 1211062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.